Page 8 - Nasdaq Podd News Today

Insulet (NASDAQ:PODD – Get Free Report) had its price target reduced by equities researchers at Barclays from $329.00 to $257.00 in a note issued to investors on Thursday, MarketBeat.com reports. The firm presently has an “equal weight” rating on the medical instruments supplier’s stock. Barclays‘s price objective points to a potential upside of 14.08% from […]

Insulet (NASDAQ:PODD – Free Report) had its price target decreased by Wells Fargo & Company from $375.00 to $330.00 in a research note issued to investors on Wednesday morning, FlyOnTheWall reports. A number of other research firms have also weighed in on PODD. UBS Group raised their target price on Insulet from $328.00 to $360.00 […]

Insulet Co. (NASDAQ:PODD – Get Free Report)’s stock price fell 8.4% during trading on Tuesday . The stock traded as low as $238.16 and last traded at $238.85. 1,466,170 shares changed hands during trading, an increase of 119% from the average session volume of 669,609 shares. The stock had previously closed at $260.85. Analyst Upgrades […]

Artemis Investment Management LLP decreased its holdings in Insulet Co. (NASDAQ:PODD – Free Report) by 9.7% in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 5,006 shares of the medical instruments supplier’s stock after selling 537 shares during the quarter. Artemis Investment Management LLP’s […]

Virtu Financial LLC purchased a new stake in Insulet Co. (NASDAQ:PODD – Free Report) in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The fund purchased 2,500 shares of the medical instruments supplier’s stock, valued at approximately $797,000. Other institutional investors and hedge funds have also recently […]

Pictet & Cie Europe SA cut its position in shares of Insulet Co. (NASDAQ:PODD – Free Report) by 37.1% during the first quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 958 shares of the medical instruments supplier’s stock after selling 564 shares during the period. Pictet & […]

Abrdn plc boosted its stake in shares of Insulet Co. (NASDAQ:PODD – Free Report) by 8.0% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 352,988 shares of the medical instruments supplier’s stock after buying an additional 26,289 shares during the period. […]

Insulet (NASDAQ:PODD – Free Report) had its price target cut by Citigroup from $330.00 to $319.00 in a research report released on Monday, FlyOnTheWall reports. A number of other equities research analysts also recently issued reports on the stock. Barclays boosted their price objective on shares of Insulet from $292.00 to $329.00 in a research […]

Jackson Square Capital LLC reduced its stake in shares of Insulet Co. (NASDAQ:PODD – Free Report) by 0.9% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 6,416 shares of the medical instruments supplier’s stock after selling 61 shares during the quarter. Jackson Square Capital […]

GPS Wealth Strategies Group LLC bought a new position in shares of Insulet Co. (NASDAQ:PODD – Free Report) in the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 240 shares of the medical instruments supplier’s stock, valued at approximately $77,000. Other large investors […]